Search results
Of which, 47 patients received combination therapy with Tamsulosin plus Finasteride and 45 patients received monotherapy with Tamsulosin once daily at bed time. Results: The baseline demographic variables were comparable in both groups.
Treatment of symptomatic benign prostatic hyperplasia (BPH) in men w/ enlarged prostate; to improve symptoms, reduce the risk of the need for surgery including transurethral resection of the prostate & prostatectomy; reduce the risk of symptomatic progression of BPH.
At the end of 6 months, tamsulosin monotherapy and combination therapy appear to be equally effective in the treatment of lower urinary tract symptoms BPH while finasteride monotherapy appears to be the least effective. Bothersome, side effects were more in patients taking finasteride alone or as combination therapy.
Jun 7, 2021 · To perform a prospective, randomized, single center study to investigate the efficacy of combined use of curcumin, an anti-inflammatory agent, with the best standard management (BSM, tamsulosin and finasteride) in benign prostatic hyperplasia (BPH) patients.
Oct 6, 2010 · Two small trials reported no difference in urinary symptom scores between finasteride and tamsulosin. Finasteride + doxazosin and doxazosin monotherapy improved urinary symptoms equally well (≥ 4 point improvement). For finasteride, there was an increased risk of ejaculation disorder, impotence, and lowered libido, versus placebo.
Mar 11, 2019 · The combination of tamsulosin plus dutasteride provides a preferable therapeutic effect for BPH with a higher incidence of sexual side effects, but combination-therapy can markedly reduce risk of BPH-related symptom progression and acute urinary retention relative to tamsulosin monotherapy.
Jul 12, 2022 · Finasteride (Proscar) and tamsulosin (Flomax) are two medications FDA approved for treating benign prostatic hyperplasia (BPH). Both medications help with urinary symptoms of BPH, such as a weak urine stream.
